Thrivent Financial for Lutherans’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
75,439
-1,199
| -2% | -$4.07K | ﹤0.01% | 2342 |
|
|
2025
Q1 | $307K | Sell |
76,638
-4,009
| -5% | -$16.1K | ﹤0.01% | 2222 |
|
|
2024
Q4 | $523K | Sell |
80,647
-3,001
| -4% | -$19.5K | ﹤0.01% | 2238 |
|
|
2024
Q3 | $463K | Buy |
83,648
+4,096
| +5% | +$22.7K | ﹤0.01% | 2273 |
|
|
2024
Q2 | $444K | Sell |
79,552
-6,290
| -7% | -$35.1K | ﹤0.01% | 2267 |
|
|
2024
Q1 | $576K | Sell |
85,842
-2,329
| -3% | -$15.6K | ﹤0.01% | 2178 |
|
|
2023
Q4 | $804K | Sell |
88,171
-2,880
| -3% | -$26.3K | ﹤0.01% | 1973 |
|
|
2023
Q3 | $503K | Buy |
91,051
+14,479
| +19% | +$80K | ﹤0.01% | 2130 |
|
|
2023
Q2 | $654K | Buy |
+76,572
| New | +$654K | ﹤0.01% | 2064 |
|